ETN startup Stone Mountain Tech maps capital, foresees global reach, hundreds of homegrown E.TN jobs.
A rigorous study of TN lifesciences is afoot and advocates are clearly positioning to push for public and private support.
Biannual Science & Technology Index shows some TN gains, but weakspots among growth factors
Franklin entrepreneur says eventual IPO is only exit option he's focused on, given global demand for ID assurance.
Chair's experience brings continuity, clear sense of value of legislative ties and momentum.
Startup's expanding universe of advisors, allies and potential funders may be approaching critical mass.
Startup commercializing VU IP to reduce injury, death and mitigate $50BN annual medical spend.
[updated] Startup has already won key role in creating Canada's digital marketplace for licensing.
LaunchTN CEO agrees it'd be great to have more data and analyses about all this.
Tech-dev exec, active Angel with Bioenergy interests surveys the region.
Aging patented technologies might have fresh potential.
[Updated] About 16 years into his mission, CEO Renkis gears for Internet of Things video leadership.
VTC State's AgLaunch initiative should get a boost, along with allies.
Imminent Seed-raise push driven by twin-pronged strategy.
Exec sees new digs, job growth, sales - plus cultural + media challenges.
The small NTC must weigh carefully its forays into State and Federal policy-shaping.
Commissioner now also presides over board of Tennessee Technology Development Corp.
Nashville VC's Oak Ridge affiliate has focused one of its startups on commercializing 'the Moses effect'
' Overhaul and investment ' could lead to accelerated enterprise development from VU research and development
Law firm broadens its already sizeable footprint, plants flag in dealing with early-stage ventures
A Nashville MoonPie? Plus, a Claritas exec on i-couponing and Innova walks away from an interesting technology
Vanderbilt pharma program inches cautiously toward tech transfer, while key faculty member keeps firm hand on the tiller
Now, after selling its first FDA-approved product to a close ally, BioMimetic is flush with cash and experience -- and committed to developing biotechnologies in Middle Tennessee.
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: